<DOC>
	<DOCNO>NCT00209560</DOCNO>
	<brief_summary>The purpose study determine safety , tolerability , efficacy AQUAVAN® Injection use mild-to-moderate sedation patient undergo minor surgical procedure .</brief_summary>
	<brief_title>A Study AQUAVAN® Injection Presence Pre-Medication Patients Undergoing Minor Surgical Procedures</brief_title>
	<detailed_description>Randomized , open label , multi-center , midazolam adaptive dose range study , several dose level AQUAVAN® Injection fentanyl citrate injection investigate produce desire sedation level patient undergo minor surgical and/or therapeutic procedure . A desired sedative dose/dose range dose paradigm identify base pre-set criterion use Modified Observer 's Assessment Alertness/Sedation ( OAA/S ) . The desired sedative dose/dose range dose paradigm AQUAVAN® Injection define one consistently provide mild moderate sedation ( Modified OAA/S 2 4 inclusive ) majority patient pre-medicated fentanyl citrate injection . Midazolam widely use i.v . agent minimal-to-moderate sedation . The dose range midazolam induce minimal moderate sedation base standard clinical practice . [ new paragraph ] All patient pre-medicated fentanyl citrate analgesic . The outpatient setting become increasingly popular various type medical procedure require sedation . In outpatient minor surgical procedure , sedation agent use provide mild-to-moderate sedation use medicine pain management . Surgeons search alternative treatment use outpatient setting would provide fast recovery time minimal post-procedure amnesia . This injection use follow pretreatment fentanyl citrate pain management .</detailed_description>
	<mesh_term>Carpal Tunnel Syndrome</mesh_term>
	<mesh_term>Fospropofol</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>1 . Patient provide signed/dated Informed Consent HIPAA Authorization receive full explanation extent nature study . 2 . Patient least 18 year age time screen . ( Prior Amendment 1 , date 03 February 2005 , criterion restrict enrollment patient ≥18 ≤65 year age . To ensure safe dosing level administer patient &gt; 65 year age , AQUAVAN midazolam dosing level reduce compare patient 18 65 year age , inclusive . The majority patient enrol prior 03 February 2005 . ) 3 . Female patient must surgically sterile , postmenopausal , pregnant lactating , must use acceptable method birth control least 1 month prior dose , negative urine pregnancy test result screen predosing period . 4 . Patient meet American Society Anesthesiologists ( ASA ) Physical Status Classification System I III . 5 . Patient may inpatient outpatient schedule undergo single minor surgical and/or therapeutic procedure . 1 . Patient history allergic reaction hypersensitivity anesthetic agent , narcotic , benzodiazepine . 2 . Patient meet nil per o ( NPO ) status per ASA Guideline institution 's guideline . 3 . Patient condition ( ) , opinion Investigator , could interfere appropriate airway management . 4 . Patient participate investigational drug study within 1 month prior study start . 5 . Patient history mental visual impairment would permit successful measurement cognitive evaluation . 6 . Patient unwilling adhere pre postprocedural instruction . 7 . The use fentanyl midazolam contraindicate patient . 8 . Patient experience multiple concurrent injury trauma . 9 . Patient schedule undergo multiple sameday procedure ( eg , bunionectomies foot ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>AQUAVAN® Injection</keyword>
	<keyword>Midazolam</keyword>
	<keyword>Minor surgical procedure</keyword>
	<keyword>Sedation</keyword>
</DOC>